Loading company…
Proclara Biosciences develops therapeutics for neurodegenerative diseases.
Founded in 2006 and based in Cambridge, US, Proclara Biosciences develops therapeutic candidates for neurodegenerative diseases. It serves healthcare providers and research institutions. In November 2018, it raised USD 9.92 mn in venture funding, among 11 investment deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in